The Effect of MK 0633 in Patients With Atherosclerosis (0633-008)(COMPLETED)
Clinical trial NCT00421278 · COMPLETED
Trial details
- NCT number
- NCT00421278
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2006-11-01
- Primary completion
- 2006-12-01
- Enrollment
- 180
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.